Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	AGN 214868 130µg	64
Overall Study	STARTED	AGN 214868 65µg	63
Overall Study	STARTED	AGN 214868 32.5µg	30
Overall Study	STARTED	Placebo	123
Overall Study	COMPLETED	AGN 214868 130µg	54
Overall Study	COMPLETED	AGN 214868 65µg	51
Overall Study	COMPLETED	AGN 214868 32.5µg	28
Overall Study	COMPLETED	Placebo	105
Overall Study	NOT COMPLETED	AGN 214868 130µg	10
Overall Study	NOT COMPLETED	AGN 214868 65µg	12
Overall Study	NOT COMPLETED	AGN 214868 32.5µg	2
Overall Study	NOT COMPLETED	Placebo	18

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01678924/flow